Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 9 Breast 5 Thoracic 3 Tumor-Agnostic 2 Sarcoma 2 Gynecologic 2 Dermatologic 2 Lymphoid 1 Head & Neck 1 Genitourinary 1 CNS 1

Conditions

Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1

Interventions

Temozolomide 79 Magnetic Resonance Spectroscopy 68 Specimen Handling 45 Radiotherapy 42 Bevacizumab 29 Radiosurgery 27 Cyclophosphamide 27 Radiation 20 pembrolizumab 19 Blood Specimen Collection 19 fludarabine 16 Nivolumab 16 Irinotecan 15 Carboplatin 13 Biopsy 13 Etoposide 12 Vincristine 11 Pemetrexed 11 Lomustine 11 dinutuximab 9 Surgical Procedures, Operative 9 trametinib 8 abemaciclib 8 Ipilimumab 8 naxitamab 7 fluciclovine F-18 7 Watchful Waiting 7 Topotecan 7 Proton Therapy 7 Magnetic Resonance Imaging 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liquid Biopsy × CNS × Clear all

NCT06515860 2026-01-09

NF1-TED

Boston Children's Hospital

Neurofibromatosis 1, Neurofibroma, Plexiform, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡